MedTrace Logo

Clinical Investigation of Omega Refractive Capsule, Model VI

NCT04574115 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2023-03-29

No results posted yet for this study

Summary

The objective of this study is to evaluate the safety and effectiveness of the investigational Omega Refractive Capsule (model VI)

Conditions

  • Cataract

Interventions

DEVICE

Omega Refractive Capsule with an FDA approved Intraocular Lens

Omega refractive capsule in conjunction with an FDA approved Intraocular Lens

DEVICE

FDA approved Intraocular Lens

FDA approved Intraocular Lens

Sponsors & Collaborators

  • Omega Ophthalmics

    lead INDUSTRY

Principal Investigators

  • Claudio Orlich, MD

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-02-06
Primary Completion
2024-06-30
Completion
2024-06-30

Countries

  • Costa Rica

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04574115 on ClinicalTrials.gov